Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
Meer behandelopties, flexibeler inzetbaar en uniformer gemonitord
mrt 2024 | Multipele Sclerose, Stamceltransplantatie, Vaccinatie